LUCHIN, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 1.186
EU - Europa 212
AS - Asia 197
SA - Sud America 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.604
Nazione #
US - Stati Uniti d'America 1.184
CN - Cina 120
UA - Ucraina 58
SG - Singapore 50
DE - Germania 46
GB - Regno Unito 33
SE - Svezia 22
TR - Turchia 22
FI - Finlandia 15
IT - Italia 15
BE - Belgio 11
BR - Brasile 6
RU - Federazione Russa 5
FR - Francia 4
AU - Australia 2
CA - Canada 2
CY - Cipro 1
CZ - Repubblica Ceca 1
EU - Europa 1
IE - Irlanda 1
IN - India 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
RO - Romania 1
Totale 1.604
Città #
Ashburn 288
Woodbridge 165
Fairfield 97
Chandler 80
Ann Arbor 73
Jacksonville 72
Houston 65
Santa Clara 43
Singapore 43
Seattle 34
Cambridge 31
Wilmington 30
Beijing 29
Addison 26
Nanjing 23
Izmir 19
Princeton 15
Milan 13
Boardman 12
Shanghai 12
Brussels 11
Dearborn 9
Changsha 7
Hebei 6
San Diego 6
Jinan 5
Kunming 5
Los Angeles 5
Guangzhou 4
Nanchang 4
San Mateo 4
Shenyang 4
Washington 4
Falkenstein 3
Leawood 3
Norwalk 3
Taizhou 3
Chicago 2
Des Moines 2
Jiaxing 2
New York 2
Ottawa 2
Tappahannock 2
Tianjin 2
Acton 1
Almaty 1
Ardabil 1
Augusta 1
Bremen 1
Brno 1
Campinas 1
Dublin 1
Falls Church 1
Ferrara 1
Formia 1
Fortaleza 1
Handan 1
Hangzhou 1
Helsinki 1
Langfang 1
Lappeenranta 1
London 1
Maricá 1
Mauá 1
Monmouth Junction 1
Mountain View 1
Mumbai 1
Nicosia 1
North Bergen 1
Nuremberg 1
Prescot 1
Redwood City 1
Saloá 1
Shijiazhuang 1
São Paulo 1
Wuxi 1
Xi'an 1
Yellow Springs 1
Totale 1.304
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 343
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 157
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 150
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 145
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 132
miR-15a and miR-16-1 down-regulation in pituitary adenomas 114
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 93
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 91
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 90
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 75
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 75
Chemoresistance of Medullary thryroid carcinoma cells is reversed by COX-2 inhibitors in vitro through a PGE2-dependent mechanism 75
Effects of pasireotide on bronchial carcinoids in primary culture 69
Totale 1.609
Categoria #
all - tutte 6.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 0 0 0 0 0 0 0 32 24 29 21 4
2020/2021167 21 16 3 18 10 15 6 19 4 19 27 9
2021/2022184 8 21 18 5 11 5 10 6 5 11 21 63
2022/2023167 15 15 13 20 25 28 12 11 20 1 4 3
2023/2024329 6 17 3 4 7 9 3 256 3 0 0 21
2024/2025129 6 8 22 6 34 38 2 13 0 0 0 0
Totale 1.609